Confluence Investment Management LLC Novartis Ag Transaction History

Confluence Investment Management LLC

$6.67 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	BUY	$80.52 - $93.75 $317,651 - $369,843	3,945 Added 2.16%	186,547 $15.8 Million
Q1 2022 Apr 04, 2022	BUY	$80.11 - $90.62 $53,994 - $61,077	674 Added 0.37%	182,602 $16 Million
Q4 2021 Jan 04, 2022	SELL	$79.7 - $88.13 $3.37 Million - $3.73 Million	-42,311 Reduced 18.87%	181,928 $15.9 Million
Q3 2021 Oct 04, 2021	SELL	$81.78 - $95.14 $3.36 Million - $3.91 Million	-41,139 Reduced 15.5%	224,239 $18.3 Million
Q2 2021 Jul 01, 2021	BUY	$85.24 - $94.15 $1.24 Million - $1.37 Million	14,547 Added 5.8%	265,378 $24.2 Million
Q1 2021 Apr 05, 2021	BUY	$83.5 - $98.47 $309,534 - $365,028	3,707 Added 1.5%	250,831 $21.4 Million
Q4 2020 Jan 25, 2021	SELL	$78.07 - $94.43 $303,692 - $367,332	-3,890 Reduced 1.55%	247,124 $23.3 Million
Q3 2020 Oct 19, 2020	SELL	$82.14 - $91.0 $205,678 - $227,864	-2,504 Reduced 0.99%	251,014 $21.8 Million
Q2 2020 Jul 01, 2020	BUY	$80.93 - $91.1 $216,892 - $244,147	2,680 Added 1.07%	253,518 $22.1 Million
Q1 2020 Jun 03, 2020	BUY	$70.67 - $99.01 $41,695 - $58,415	590 Added 0.24%	250,838 $20.7 Million
Q1 2020 Apr 08, 2020	BUY	$70.67 - $99.01 $1.39 Million - $1.95 Million	19,665 Added 8.53%	250,248 $20.6 Million
Q4 2019 Jun 02, 2020	SELL	$84.35 - $95.37 $1.46 Million - $1.65 Million	-17,274 Reduced 6.97%	230,583 $21.1 Million
Q4 2019 Jan 29, 2020	BUY	$84.35 - $95.37 $472,613 - $534,358	5,603 Added 2.31%	247,857 $23.5 Million
Q3 2019 Oct 15, 2019	BUY	$85.54 - $94.26 $998,337 - $1.1 Million	11,671 Added 5.06%	242,254 $21.1 Million
Q2 2019 Jul 24, 2019	BUY	$75.4 - $92.8 $910,153 - $1.12 Million	12,071 Added 5.52%	230,583 $21.1 Million
Q1 2019 Apr 16, 2019	BUY	$75.32 - $86.15 $321,013 - $367,171	4,262 Added 1.99%	218,512 $21 Million
Q4 2018 Jan 04, 2019	BUY	$73.66 - $82.02 $1.79 Million - $2 Million	24,355 Added 12.83%	214,250 $18.4 Million
Q3 2018 Oct 25, 2018	BUY	$66.94 - $77.43 $732,390 - $847,161	10,941 Added 6.11%	189,895 $16.4 Million
Q2 2018 Jul 12, 2018	BUY	$64.91 - $73.36 $613,724 - $693,618	9,455 Added 5.58%	178,954 $13.5 Million
Q1 2018 Apr 04, 2018	BUY	$70.39 - $84.15 $411,711 - $492,193	5,849 Added 3.57%	169,499 $13.7 Million
Q4 2017 Jan 08, 2018	BUY	$72.33 - $77.64 $314,635 - $337,734	4,350 Added 2.73%	163,650 $13.7 Million
Q3 2017 Oct 13, 2017	BUY	$74.14 - $77.27 $11.8 Million - $12.3 Million	159,300	159,300 $13.7 Million

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.55M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $238B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Confluence Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Confluence Investment Management LLC with notifications on news.

Account